Roberto
Barriales Villa
Tel Aviv University
Tel Aviv, IsraelPublications in collaboration with researchers from Tel Aviv University (7)
2024
-
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American Heart Association, Vol. 13, Núm. 15, pp. e035993
-
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831
2023
-
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome
Heart Rhythm, Vol. 20, Núm. 10, pp. 1385-1392
2022
-
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2301-2312
2019
-
The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy
European Heart Journal, Vol. 40, Núm. 21, pp. 1671-1677
2016
-
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451
2015
-
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
Heart, Vol. 101, Núm. 13, pp. 1047-1053